-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Protagonist Therapeutics, Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2024.
- Protagonist Therapeutics, Inc Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.54 USD/shares, a 6.9% increase year-over-year.
- Protagonist Therapeutics, Inc Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 2.91 USD/shares.
- Protagonist Therapeutics, Inc annual Earnings Per Share, Basic for 2023 was -1.39 USD/shares, a 46.5% increase from 2022.
- Protagonist Therapeutics, Inc annual Earnings Per Share, Basic for 2022 was -2.6 USD/shares, a 4.06% increase from 2021.
- Protagonist Therapeutics, Inc annual Earnings Per Share, Basic for 2021 was -2.71 USD/shares, a 41.1% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)